Immunotherapy Combination Is Active in Patients With Melanoma Brain Metastases – Curetoday.com
|
Immunotherapy Combination Is Active in Patients With Melanoma Brain Metastases
Curetoday.com Immunotherapy Combination Is Active in Patients With Melanoma Brain Metastases. Opdivo (nivolumab) plus Yervoy (ipilimumab) demonstrated a response in some patients with melanoma brain metastases, according to a recent study presented at ASCO. |
